International Experience with a New Single 2 Gram Dose of Tinidazole (‘Fasigyn’)

Summary

The results of studies carried out in 10 European Medical Centres have shown the efficacy and safety of a new 2 gram single-dose regime of tinidazole. Two hundred and fifty-one patients were treated and an efficacy of greater than 95 % was observed. The toleration was good, side-effects were self-limiting and mild. The results of several studies which were performed outside Europe are also reported. These were in agreement with those observed in Europe and were consistently excellent irrespective of geographical or racial characteristics. The new tinidazole dosage regime can now be considered an established method of oral antitrichomonal therapy.

Key words: :

• Tinidazole
• antitrichomonal agents
• trichomonal vaginitis